Reference is made to the private placement (the “Private Placement“) and the retail offering through PrimaryBid announced by Zelluna ASA on 3 November 2025. Please see the attached PDMR-form related to share lending to facilitate settlement of listed shares in tranche 2 of the Private Placement.
Attachment
February 06, 2026 16:01 ET | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…
February 06, 2026 16:01 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…
New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…
AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…
Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…
February 06, 2026 17:17 ET | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…